Related Experiment Videos
The precipitating factor in coeliac disease
1German Research Institute of Food chemistry, Garching.
Bailliere'S Clinical Gastroenterology
|June 1, 1995
Summary
Researchers identified specific peptide sequences in wheat gluten, such as Pro-Ser-Gln-Gln, as key contributors to coeliac disease toxicity. These gluten proteins, particularly alpha-type gliadins, trigger immune responses, highlighting potential targets for therapeutic interventions.
Area of Science:
- Food Science and Nutrition
- Immunology
- Biochemistry
Background:
- Celiac disease is triggered by gluten proteins found in wheat, barley, and rye.
- Gluten proteins are classified into high-, medium-, and low-molecular-weight groups, each with distinct structural elements.
- Previous research implicated alcohol-soluble gliadin fractions as toxic components.
Purpose of the Study:
- To elucidate the specific cereal protein structures responsible for coeliac toxicity.
- To identify the key amino acid sequences within gluten proteins that activate coeliac disease.
- To investigate the structural and conformational properties of toxic gluten peptides.
Main Methods:
- Classification of gluten proteins based on molecular weight and structural domains.
- In-vivo (instillation) and in-vitro (organ culture) testing of gliadin peptides.
- Analysis of amino acid sequences for common motifs in toxic peptides.
- In-vitro and in-vivo studies on synthetic peptides to confirm toxicity.
Main Results:
- Alpha-type gliadins were identified as toxic, with the N-terminal region (domain I) being crucial for coeliac disease activation.
- The peptide sequences -Pro-Ser-Gln-Gln- and -Gln-Gln-Gln-Pro- were found to be common in toxic gliadin peptides.
- These toxic sequences are rich in glutamine and proline, characterized by repetitive structures and the ability to form beta-turn conformations.
- These specific sequences are absent in non-toxic food proteins.
Conclusions:
- The identified peptide sequences are critical for the toxic effects of gluten in coeliac disease.
- These sequences, while not solely sufficient, represent a starting point for understanding gluten toxicity.
- Further research into these sequences may lead to novel therapeutic strategies for coeliac disease.